Gabor Boka und Diabetes - Info zur Person

(1 - 15 von 19

)

Injectable Drug Works for Diabetes | RxWiki

www.rxwiki.com

Two researchers involved in the study - Gabor Boka, MD, and Patrick Miossec, MD - are employees of Sanofi. Conditions: Type 2 Diabetes ...

LinkedIn: Gabor Boka | LinkedIn

Gabor Bokas berufliches Profil anzeigen LinkedIn ist das weltweit größte berufliche Netzwerk, das Fach- und Führungskräften wie Gabor Boka dabei hilft, ...

LinkedIn: Gabor Boka, MD - Associate VP, Head of Operational Medical ...fr.linkedin.com › gabor-boka-md-...

Voir le profil de Gabor Boka, MD sur LinkedIn, le plus grand réseau professionnel mondial. Gabor a 3 postes sur son profil. Consultez le profil complet sur ...

Full text of "Efficacy and Safety of the Once-Daily GLP-1 Receptor...

archive.org

... patients with type 2 diabetes (GetGoal-Mono) Vivian A. Fonseca, md'^ RiCARDO Alvarado-Ruiz, md'^ Denis Raccah, md^ Gabor Boka, md"*^ Patrick Miossec, ...

Efficacy and Safety of Lixisenatide Once Daily Versus ...diabetesjournals.org

diabetesjournals.org

von J Rosenstock · · Zitiert von: 297 — GABOR BOKA, MD. 5. PATRICK MIOSSEC, MD. 6. JOHN E. GERICH, MD. 7. OBJECTIVEdTo compare efficacy and safety of lixisenatide once daily versus exenatide twice.

препаратов для медицинскогоendocrincentr.ru

www.endocrincentr.ru

Gabor Boka, Patrick. Miossec, John E. Gerich. Efficacy and. Safety of Lixisenatide. Once Daily Versus. Exenatide Twice Daily in Type 2 Diabetes. Inadequately.

Efficacy and Safety of Lixisenatide Once-Daily [italic]vs[/italic ...professional.diabetes.org › abstract

professional.diabetes.org

[figure1] JULIO ROSENSTOCK, DENIS RACCAH, LASZLO KORANYI, LAURA MAFFEI, GABOR BOKA, PATRICK MIOSSEC, JOHN E. GERICH 33-LB Dallas, TX, ...

Prevention of hypoglycaemia in diabetes mellitus type Google Patents

patents.google.com

Gabor Boka: Patrick Miossec. Worldwide applications EP. Application number: EP A. Filing date: Legal status: Ceased. BR. Application ...

Gabor Boka Email and Phone NumberAeroLeads

aeroleads.com

Gabor Boka's role in his workplace is Associate Vice President, Head Of Operational Medical Development - Diabetes, Cardiovascular And Metabolism . Which ...

Beneficial effects of once-daily lixisenatide on overall and ...National Institutes of Health (NIH) (.gov)

pubmed.ncbi.nlm.nih.gov

von J Rosenstock · · Zitiert von: 137 — ... Gabor Boka , Patrick Miossec , Tianyue Zhou , Isabel Muehlen-Bartmer , Robert E Ratner. Affiliations. 1 Dallas Diabetes and Endocrine Center at ...

Diabetes care , Vol. 35, Nº DialnetDialnet

dialnet.unirioja.es

Fonseca, Ricardo Alvarado Ruiz, Denis Raccah, Gabor Boka, Patrick Miossec, John E. Gerich · Resumen · Texto completo. págs Artículo. Dose-Ranging ...

Dr. John Gerich, MD – Wayne, PA | EndocrinologyDoximity

www.doximity.com

... Gabor Boka, Patrick Miossec, John E. Gerich> ;Diabetes Care May 22; 165 citations. Efficacy and Safety of the Once-Daily GLP-1 Receptor Agonist ...

Patents Related To "Hemifacial Spasm As The Presenting ...expertkg.com

www.expertkg.com

GABOR BOKA et. al. GABOR BOKA et. al. SANOFI-AVENTIS DEUTSCHLAND GMBHUse of AVE0010 for the Treatment of Diabetes Mellitus Type 2 · Related ...

Efficacy and Safety of the Once-Daily GLP-1 Receptor Agonist...

diabetesjournals.org

OBJECTIVE. To …s efficacy and safety of lixisenatide monotherapy in type 2 diabetes.RESEARCH DESIGN AND METHODS. Randomized, double-blind, 12-week study of

Diabetes care Dialnet

dialnet.unirioja.es

Información de la revista Diabetes care

Alle Infos zum Namen "Gabor Boka"

Verwandte Suchanfragen zu Gabor Boka

Julijana Robert Molnar
Gabor Dalecker

Personen
Vorname "Gabor" (1513)
Name "Boka" (66)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Gabor Boka und Diabetes Person-Info